Macrophages in experimental and human brain tumors. Part 1: Studies of the macrophage content of experimental rat brain tumors of varying immunogenicity.
Although the presence of lymphoreticular cells within tumors has been recognized for over 100 years, it is only within the last decade that the concept has arisen that standard histological examination techniques may lead to an underestimation of the true extent of tumor infiltration by lymphoreticular cells, and particularly by macrophages. The macrophage content of certain systemic tumors has been correlated with their immunogenicity and growth characteristics. Since the central nervous system is to some extent an "immunologically privileged site" and contains within it specialized reticuloendothelial cells called microglia, the authors determined the macrophage content of three rodent brain-tumor cell lines, and attempted to correlate this macrophage content with their immunogenicity and growth characteristics. Their findings indicate a direct correlation between the immunogenicity and macrophage content of these three neural tumor cell lines.
D000818:Animals; D001932:Brain Neoplasms / Q000276:immunology / Q000473:pathology*; D005910:Glioma / Q000473:pathology; D007109:Immunity; D008264:Macrophages / Q000187:drug effects / Q000473:pathology*; D008297:Male; D009374:Neoplasms, Experimental / Q000276:immunology / Q000473:pathology; D051381:Rats; D012513:Sarcoma, Experimental / Q000473:pathology; D012822:Silicon Dioxide / Q000494:pharmacology
D012822:Silicon Dioxide